HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nature's Way

This article was originally published in The Tan Sheet

Executive Summary

Supplement firm's first children's vitamin, VitaPals, are shaped like a puppy's head and come in "tangy orange" flavored vitamin C tablets and "juicy grape" multis. The non-caryogenic vitamins are available in 60- and 120-counts as well as a combination pack that includes a 60-count of each and a stuffed puppy toy. VitaPals began shipping in late March. The firm additionally is introducing its Fisol enteric-coated fish oil softgels containing 150 mg eicosapentanoic acid and 100 mg docosahexanoic acid, as well as Primadophilus Reuteri, a probiotic supplement (1see story, p. 10)

You may also be interested in...



Probiotic Category Expanding With New Product Launches

The recent enthusiasm for probiotics as a promising growth area appears to be on the rise as several companies, including Nature's Way, Wakunaga of America, Enzymatic Therapy and Jarrow Formulas, introduced new products at the Natural Products Expo West in Anaheim, Calif. March 23-26.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

OM013057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel